SC
CVS icon

Sierra Capital’s CVS Health CVS Stock Holding History

Sierra Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$745K Hold
10,378
– – 0.08% 147
2025
Q4 		$824K Hold
10,378
– – 0.09% 129
2025
Q3 		$782K Hold
10,378
– – 0.09% 146
2025
Q2 		$716K Hold
10,378
– – 0.08% 142
2025
Q1 		$703K Sell
10,378
-661
-6% -$39.6K 0.08% 141
2024
Q4 		$496K Sell
11,039
-154
-1% -$8.64K 0.06% 158
2024
Q3 		$704K Buy
11,193
+3,800
+51% +$222K 0.08% 139
2024
Q2 		$437K Hold
7,393
– – 0.06% 155
2024
Q1 		$590K Buy
+7,393
New +$565K 0.08% 141
2023
Q1 		– Sell
-904
Closed -$84K – 274
2022
Q4 		$84K Sell
904
-2
-0.2% -$193 0.01% 226
2022
Q3 		$86K Sell
906
-683
-43% -$67.6K 0.02% 231
2022
Q2 		$147K Hold
1,589
– – 0.03% 230
2022
Q1 		$161K Buy
1,589
+37
+2% +$3.89K 0.03% 237
2021
Q4 		$160K Buy
1,552
+91
+6% +$8.41K 0.02% 252
2021
Q3 		$124K Sell
1,461
-294
-17% -$24.6K 0.02% 249
2021
Q2 		$146K Hold
1,755
– – 0.03% 211
2021
Q1 		$132K Buy
+1,755
New +$128K 0.02% 221

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sierra Capital's CVS Position: Q1 2026 in Review

Sierra Capital held its CVS Health (CVS) position steady in Q1 2026 at 10,378 shares worth $745K. The position accounts for 0.08% of the portfolio, ranked #147.

Sierra Capital first reported a position in CVS in Q1 2021 and has held it in 17 quarters since. The position peaked at $824K in Q4 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Sierra Capital held 10,378 shares of CVS Health worth $745K as of Q1 2026.
  • Sierra Capital left its CVS Health share count unchanged in Q1 2026.
  • CVS Health made up 0.08% of Sierra Capital's portfolio in Q1 2026, its #147 holding.
  • Sierra Capital first reported a position in CVS Health in Q1 2021 and has held it in 17 quarters since.
  • Sierra Capital's CVS Health position peaked at $824K in Q4 2025.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Sierra Capital's 13F filing for Q1 2026, filed 15 May 2026.